BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 37474678)

  • 1. Innovative molecular subtypes of multiple signaling pathways in colon cancer and validation of FMOD as a prognostic-related marker.
    Dai Z; Peng X; Cui X; Guo Y; Zhang J; Shen X; Liu CY; Liu Y
    J Cancer Res Clin Oncol; 2023 Nov; 149(14):13087-13106. PubMed ID: 37474678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy-related gene expression classification defines three molecular subtypes with distinct clinical and microenvironment cell infiltration characteristics in colon cancer.
    Zhu S; Wu Q; Zhang B; Wei H; Li B; Shi W; Fang M; Zhu S; Wang L; Lang Zhou Y; Dong Y
    Int Immunopharmacol; 2020 Oct; 87():106757. PubMed ID: 32769067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer.
    Zou R; Jiang Q; Jin T; Chen M; Yao L; Ding H
    Front Immunol; 2022; 13():956224. PubMed ID: 36032075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. m7G-Associated subtypes, tumor microenvironment, and validation of prognostic signature in lung adenocarcinoma.
    Wang G; Zhao M; Li J; Li G; Zheng F; Xu G; Hong X
    Front Genet; 2022; 13():954840. PubMed ID: 36046251
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic pathway-based molecular subtyping of colon cancer reveals clinical immunotherapy potential and prognosis.
    Dai Z; Peng X; Guo Y; Shen X; Ding W; Fu J; Liang Z; Song J
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2393-2416. PubMed ID: 35731273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and multicohort validation of a colon cancer prognostic risk score system based on big data of neutrophil-associated differentially expressed genes.
    Yang Y; Lu C; Li L; Zheng C; Wang Y; Chen J; Sun B
    J Cancer; 2024; 15(9):2866-2879. PubMed ID: 38577604
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification and validation of a seven-gene prognostic marker in colon cancer based on single-cell transcriptome analysis.
    Zhou Y; Guo Y; Wang Y
    IET Syst Biol; 2022 Apr; 16(2):72-83. PubMed ID: 35352485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage-related molecular subtypes in lung adenocarcinoma identify novel tumor microenvironment with prognostic and therapeutic implications.
    Wen H; Chen H; Xie L; Li Z; Zhang Q; Tian Q
    Front Genet; 2022; 13():1012164. PubMed ID: 36263430
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of molecular subtypes, risk signature, and immune landscape mediated by necroptosis-related genes in non-small cell lung cancer.
    Zhu J; Wang J; Wang T; Zhou H; Xu M; Zha J; Feng C; Shen Z; Jiang Y; Chen J
    Front Oncol; 2022; 12():955186. PubMed ID: 35965497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy.
    Li C; Pan J; Luo J; Chen X
    BMC Pulm Med; 2021 Nov; 21(1):389. PubMed ID: 34844602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations Between Tumor Mutation Burden and Immunocyte Infiltration and Their Prognostic Value in Colon Cancer.
    Zhou Z; Xie X; Wang X; Zhang X; Li W; Sun T; Cai Y; Wu J; Dang C; Zhang H
    Front Genet; 2021; 12():623424. PubMed ID: 33664769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature.
    He J; Chen Z; Xue Q; Sun P; Wang Y; Zhu C; Shi W
    J Transl Med; 2022 Apr; 20(1):186. PubMed ID: 35468826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a Risk Model for Colon Cancer Prognosis Based on Ubiquitin-Related Genes.
    Hu B; Chen Z; Yao F; Li B
    Turk J Gastroenterol; 2023 May; 34(5):449-456. PubMed ID: 37158531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of gastric cancer subtypes based on pathway clustering.
    Li L; Wang X
    NPJ Precis Oncol; 2021 Jun; 5(1):46. PubMed ID: 34079012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response.
    Li C; Zhang K; Gong Y; Wu Q; Zhang Y; Dong Y; Li D; Wang Z
    Front Pharmacol; 2023; 14():1200054. PubMed ID: 37377924
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of natural killer cell-related characteristics to predict the clinical prognosis and immune microenvironment of patients with low-grade glioma.
    Sun F; Lv H; Feng B; Sun J; Zhang L; Dong B
    Aging (Albany NY); 2023 Jul; 15(13):6264-6291. PubMed ID: 37405952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive
    Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
    Front Immunol; 2022; 13():931906. PubMed ID: 35958598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.